SPONSOR
Eloxx Pharmaceuticals, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 2
Eloxx Pharmaceuticals, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Alport Syndrome, X-Linked, Alport Syndrome, Autosomal Recessive.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Eloxx Pharmaceuticals, Inc.
How many clinical trials has Eloxx Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Eloxx Pharmaceuticals, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Alport Syndrome, X-Linked, Alport Syndrome, Autosomal Recessive. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Eloxx Pharmaceuticals, Inc. research focus on?
Eloxx Pharmaceuticals, Inc. clinical trials span Alport Syndrome, X-Linked, Alport Syndrome, Autosomal Recessive. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Eloxx Pharmaceuticals, Inc. clinical trial?
To participate in a Eloxx Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Eloxx Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Eloxx Pharmaceuticals, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology